drugset / Trial / NCT02734524

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

NCT02734524

Phase 2 Unknown 104 enrolled Southwest Hospital, China
RandomizedParallel-groupOpen-labelTreatment

Summary

The main purpose of this study is to explore if the combination of autologous NK cell infusion and chemotherapy can increase the therapeutic efficiency in the treatment of non-small cell lung cancer compared with chemotherapy alone.

Timeline

Start
2016-03
Primary completion
2018-03
Completion
2019-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule
Subject Paclitaxel Small molecule 135 mg/m2
Subject Paclitaxel Small molecule 175 mg/m2
Subject TROCULEUCEL Cell therapy 1e+09 cells